Effects of recombinant human IGF-I on glucose and leucine kinetics in men
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
When disposing of any unused NAD+ solution or expired vials, one should follow proper medical waste protocols: do not pour it down drains or flush it
Taken together, these data reinforce the emerging paradigm of a multimodal and personalized therapeutic approach, which will likely form the foundation of future obesity management
W.GalluzziL
In addition to IV therapy, eating bland foods such as dry cereal, saltine crackers, oatmeal, and potatoes can help ease symptoms and support recovery